AUTH:"Flotats-Bastardas M" - Search results

Efficacy and safety of gene therapy with onasemnogene abeparvovec in children with spinal muscular atrophy in the D-A-CH-region: a population-based observational study.

Weiß C, Becker LL, Friese J, Blaschek A, Hahn A, Illsinger S, Schwartz O, Bernert G, Hagen MV, Husain RA, Goldhahn K, Kirschner J, Pechmann A, Flotats-Bastardas M, Schreiber G, Schara U, Plecko B, Trollmann R, Horber V, [...] SMArtCARE and Swiss-Reg-NMD study group

Lancet Reg Health Eur, 47:101092, 07 Oct 2024

Cited by: 1 article | PMID: 39434961 | PMCID: PMC11492610

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Clinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy: A Nonrandomized Controlled Trial.

Schwartz O, Vill K, Pfaffenlehner M, Behrens M, Weiß C, Johannsen J, Friese J, Hahn A, Ziegler A, Illsinger S, Smitka M, von Moers A, Kölbel H, Schreiber G, Kaiser N, Wilichowski E, Flotats-Bastardas M, Husain RA, Baumann M, [...] SMARTCARE study group

JAMA Pediatr, 178(6):540-547, 01 Jun 2024

Cited by: 4 articles | PMID: 38587854

Add to export list

Health-related quality of life of adults with spinal muscular atrophy: insights from a nationwide patient registry in Germany.

Landfeldt E, Leibrock B, Hussong J, Thiele S, Walter MC, Moehler E, Zemlin M, Dillmann U, Flotats-Bastardas M

Qual Life Res, 33(7):1949-1959, 16 May 2024

Cited by: 1 article | PMID: 38753126

Add to export list

Different pain phenotypes are associated with anti-Caspr2 autoantibodies.

Greguletz P, Plötz M, Baade-Büttner C, Bien CG, Eisenhut K, Geis C, Handreka R, Klausewitz J, Körtvelyessy P, Kovac S, Kraft A, Lewerenz J, Malter M, Nagel M, von Podewils F, Prüß H, Rada A, Rau J, Rauer S, [...] GENERATE study group

J Neurol, 271(5):2736-2744, 22 Feb 2024

Cited by: 1 article | PMID: 38386048 | PMCID: PMC11055745

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational study.

Günther R, Wurster CD, Brakemeier S, Osmanovic A, Schreiber-Katz O, Petri S, Uzelac Z, Hiebeler M, Thiele S, Walter MC, Weiler M, Kessler T, Freigang M, Lapp HS, Cordts I, Lingor P, Deschauer M, Hahn A, Martakis K, [...] Hagenacker T

Lancet Reg Health Eur, 39:100862, 06 Feb 2024

Cited by: 5 articles | PMID: 38361750 | PMCID: PMC10864329

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

5qSMA: standardised retrospective natural history assessment in 268 patients with four copies of SMN2.

Vill K, Tacke M, König A, Baumann M, Baumgartner M, Steinbach M, Bernert G, Blaschek A, Deschauer M, Flotats-Bastardas M, Friese J, Goldbach S, Gross M, Günther R, Hahn A, Hagenacker T, Hauser E, Horber V, Illsinger S, [...] SMArtCARE study group

J Neurol, 271(5):2787-2797, 27 Feb 2024

Cited by: 0 articles | PMID: 38409538 | PMCID: PMC11055798

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Self-Reported Health-Related Quality of Life of Children with Spinal Muscular Atrophy: Preliminary Insights from a Nationwide Patient Registry in Germany.

Landfeldt E, Leibrock B, Hussong J, Thiele S, Abner S, Walter MC, Moehler E, Zemlin M, Dillmann U, Flotats-Bastardas M

J Neuromuscul Dis, 11(1):117-128, 01 Jan 2024

Cited by: 2 articles | PMID: 38108360 | PMCID: PMC10789359

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Paradoxical increase of neurofilaments in SMA patients treated with onasemnogene abeparvovec-xioi.

Flotats-Bastardas M, Bitzan L, Grell C, Martakis K, Winter B, Zemlin M, Wurster CD, Uzelac Z, Weiß C, Hahn A

Front Neurol, 14:1269406, 13 Dec 2023

Cited by: 0 articles | PMID: 38162454 | PMCID: PMC10756901

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Alterations in pathogen-specific cellular and humoral immunity associated with acute peripheral facial palsy of infectious origin.

Mohammad L, Fousse M, Wenzel G, Flotats Bastardas M, Faßbender K, Dillmann U, Schick B, Zemlin M, Gärtner BC, Sester U, Schub D, Schmidt T, Sester M

J Neuroinflammation, 20(1):246, 25 Oct 2023

Cited by: 0 articles | PMID: 37880696 | PMCID: PMC10598953

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Alterations in pathogen-specific cellular and humoral immunity associated with acute peripheral facial palsy of infectious origin

Mohammad L, Fousse M, Wenzel G, Flotats-Bastardas M, Faßbender K, Dillmann U, Schick B, Zemlin M, Gärtner BC, Sester U, Schub D, Schmidt T, Sester M

medRxiv, 16 Aug 2023

Cited by: 0 articles | PPR: PPR706144

Add to export list Preprint

[Assessment of the importance of neuropediatric diagnostics in the initial clarification of autism].

Ruffing S, Ullrich C, Flotats-Bastardas M, Poryo M, Meyer S

Wien Med Wochenschr, 174(11-12):231-241, 03 May 2023

Cited by: 0 articles | PMID: 37133629 | PMCID: PMC11347487

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

A genome-wide association study in autoimmune neurological syndromes with anti-GAD65 autoantibodies.

Strippel C, Herrera-Rivero M, Wendorff M, Tietz AK, Degenhardt F, Witten A, Schroeter C, Nelke C, Golombeck KS, Madlener M, Rüber T, Ernst L, Racz A, Baumgartner T, Widman G, Doppler K, Thaler F, Siebenbrodt K, Dik A, [...] German Network for Research on Autoimmune Encephalitis (GENERATE)

Brain, 146(3):977-990, 01 Mar 2023

Cited by: 7 articles | PMID: 35348614 | PMCID: PMC9976967

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Areas of improvement in the medical care of SMA: evidence from a nationwide patient registry in Germany.

Leibrock B, Landfeldt E, Hussong J, Huelle T, Mattheus H, Thiele S, Walter MC, Zemlin M, Moehler E, Dillman U, Abner S, Flotats-Bastardas M

Orphanet J Rare Dis, 18(1):32, 21 Feb 2023

Cited by: 5 articles | PMID: 36810103 | PMCID: PMC9945617

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Improvements in Walking Distance during Nusinersen Treatment - A Prospective 3-year SMArtCARE Registry Study.

Pechmann A, Behrens M, Dörnbrack K, Tassoni A, Wenzel F, Stein S, Vogt S, Zöller D, Bernert G, Hagenacker T, Schara-Schmidt U, Walter MC, Steinbach M, Blaschek A, Baumann M, Baumgartner M, Becker B, Flotats-Bastardas M, Friese J, [...] SMArtCARE Study Group

J Neuromuscul Dis, 10(1):29-40, 01 Jan 2023

Cited by: 6 articles | PMID: 36565133 | PMCID: PMC9881023

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 disease.

Grüter T, Möllers FE, Tietz A, Dargvainiene J, Melzer N, Heidbreder A, Strippel C, Kraft A, Höftberger R, Schöberl F, Thaler FS, Wickel J, Chung HY, Seifert F, Tschernatsch M, Nagel M, Lewerenz J, Jarius S, Wildemann BC, [...] German Network for Research on Autoimmune Encephalitis (GENERATE)

Brain, 146(2):600-611, 01 Feb 2023

Cited by: 37 articles | PMID: 35259208

Add to export list

Newbornscreening SMA - From Pilot Project to Nationwide Screening in Germany.

Müller-Felber W, Blaschek A, Schwartz O, Gläser D, Nennstiel U, Brockow I, Wirth B, Burggraf S, Röschinger W, Becker M, Durner J, Eggermann K, Kölbel H, Müller C, Hannibal I, Olgemöller B, Schara U, von Moers A, Trollmann R, [...] Vill K

J Neuromuscul Dis, 10(1):55-65, 01 Jan 2023

Cited by: 14 articles | PMID: 36463459 | PMCID: PMC9881029

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Effect of nusinersen on motor, respiratory and bulbar function in early-onset spinal muscular atrophy.

Pechmann A, Behrens M, Dörnbrack K, Tassoni A, Stein S, Vogt S, Zöller D, Bernert G, Hagenacker T, Schara-Schmidt U, Schwersenz I, Walter MC, Baumann M, Baumgartner M, Deschauer M, Eisenkölbl A, Flotats-Bastardas M, Hahn A, Horber V, [...] SMArtCARE study group

Brain, 146(2):668-677, 01 Feb 2023

Cited by: 17 articles | PMID: 35857854

Add to export list

Improved upper limb function in non-ambulant children with SMA type 2 and 3 during nusinersen treatment: a prospective 3-years SMArtCARE registry study.

Pechmann A, Behrens M, Dörnbrack K, Tassoni A, Wenzel F, Stein S, Vogt S, Zöller D, Bernert G, Hagenacker T, Schara-Schmidt U, Walter MC, Bertsche A, Vill K, Baumann M, Baumgartner M, Cordts I, Eisenkölbl A, Flotats-Bastardas M, [...] SMArtCARE study group

Orphanet J Rare Dis, 17(1):384, 23 Oct 2022

Cited by: 11 articles | PMID: 36274155 | PMCID: PMC9589836

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Mitochondrial diseases mimicking autoimmune diseases of the CNS and good response to steroids initially.

Della Marina A, Bertolini A, Wegener-Panzer A, Flotats-Bastardas M, Reinhardt T, El Naggar I, Distelmaier F, Blaschek A, Schara-Schmidt U, Brunet T, Wagner M, Smirnov D, Prokisch H, Wortmann SB, Rostasy K

Eur J Paediatr Neurol, 41:27-35, 20 Sep 2022

Cited by: 2 articles | PMID: 36162141

Add to export list

[Pseudotumor cerebri in children and adolescents at the Saarland University Medical Center: a retrospective study].

Freudenberg M, Flotats-Bastardas M, Zemlin M, Poryo M, Meyer S

Wien Med Wochenschr, 173(7-8):173-181, 08 Aug 2022

Cited by: 0 articles | PMID: 35939217

Add to export list

Cathepsin D as biomarker in cerebrospinal fluid of nusinersen-treated patients with spinal muscular atrophy.

Schorling DC, Kölbel H, Hentschel A, Pechmann A, Meyer N, Wirth B, Rombo R, SMArtCARE consortium, Sickmann A, Kirschner J, Schara-Schmidt U, Lochmüller H, Roos A

Eur J Neurol, 29(7):2084-2096, 04 May 2022

Cited by: 14 articles | PMID: 35318785

Add to export list

Genome-wide Association Study Identifies 2 New Loci Associated With Anti-NMDAR Encephalitis.

Tietz AK, Angstwurm K, Baumgartner T, Doppler K, Eisenhut K, Elisak M, Franke A, Golombeck KS, Handreka R, Kaufmann M, Kraemer M, Kraft A, Lewerenz J, Lieb W, Madlener M, Melzer N, Mojzisova H, Möller P, Pfefferkorn T, [...] German Network for Research on Autoimmune Encephalitis (GENERATE)

Neurol Neuroimmunol Neuroinflamm, 8(6):e1085, 28 Sep 2021

Cited by: 6 articles | PMID: 34584012 | PMCID: PMC8479862

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Gene replacement therapy with onasemnogene abeparvovec in children with spinal muscular atrophy aged 24 months or younger and bodyweight up to 15 kg: an observational cohort study.

Weiß C, Ziegler A, Becker LL, Johannsen J, Brennenstuhl H, Schreiber G, Flotats-Bastardas M, Stoltenburg C, Hartmann H, Illsinger S, Denecke J, Pechmann A, Müller-Felber W, Vill K, Blaschek A, Smitka M, van der Stam L, Weiss K, Weiss K, [...] Kaindl AM

Lancet Child Adolesc Health, 6(1):17-27, 29 Oct 2021

Cited by: 46 articles | PMID: 34756190

Add to export list

CSF Findings in Acute NMDAR and LGI1 Antibody-Associated Autoimmune Encephalitis.

Dürr M, Nissen G, Sühs KW, Schwenkenbecher P, Geis C, Ringelstein M, Hartung HP, Friese MA, Kaufmann M, Malter MP, Madlener M, Thaler FS, Kümpfel T, Senel M, Häusler MG, Schneider H, Bergh FT, Kellinghaus C, Zettl UK, [...] German Network for Research on Autoimmune Encephalitis

Neurol Neuroimmunol Neuroinflamm, 8(6):e1086, 25 Oct 2021

Cited by: 21 articles | PMID: 34697224 | PMCID: PMC8546742

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Rituximab Treatment and Long-term Outcome of Patients With Autoimmune Encephalitis: Real-world Evidence From the GENERATE Registry.

Thaler FS, Zimmermann L, Kammermeier S, Strippel C, Ringelstein M, Kraft A, Sühs KW, Wickel J, Geis C, Markewitz R, Urbanek C, Sommer C, Doppler K, Penner L, Lewerenz J, Rößling R, Finke C, Prüss H, Melzer N, [...] German Network for Research on Autoimmune Encephalitis (GENERATE)

Neurol Neuroimmunol Neuroinflamm, 8(6):e1088, 01 Oct 2021

Cited by: 45 articles | PMID: 34599001 | PMCID: PMC8488759

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Search life-sciences literature (45,104,145 articles, preprints and more)

Search results

Efficacy and safety of gene therapy with onasemnogene abeparvovec in children with spinal muscular atrophy in the D-A-CH-region: a population-based observational study.

Clinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy: A Nonrandomized Controlled Trial.

Health-related quality of life of adults with spinal muscular atrophy: insights from a nationwide patient registry in Germany.

Different pain phenotypes are associated with anti-Caspr2 autoantibodies.

Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational study.

5qSMA: standardised retrospective natural history assessment in 268 patients with four copies of SMN2.

Self-Reported Health-Related Quality of Life of Children with Spinal Muscular Atrophy: Preliminary Insights from a Nationwide Patient Registry in Germany.

Paradoxical increase of neurofilaments in SMA patients treated with onasemnogene abeparvovec-xioi.

Alterations in pathogen-specific cellular and humoral immunity associated with acute peripheral facial palsy of infectious origin.

Alterations in pathogen-specific cellular and humoral immunity associated with acute peripheral facial palsy of infectious origin

[Assessment of the importance of neuropediatric diagnostics in the initial clarification of autism].

A genome-wide association study in autoimmune neurological syndromes with anti-GAD65 autoantibodies.

Areas of improvement in the medical care of SMA: evidence from a nationwide patient registry in Germany.

Improvements in Walking Distance during Nusinersen Treatment - A Prospective 3-year SMArtCARE Registry Study.

Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 disease.

Newbornscreening SMA - From Pilot Project to Nationwide Screening in Germany.

Effect of nusinersen on motor, respiratory and bulbar function in early-onset spinal muscular atrophy.

Improved upper limb function in non-ambulant children with SMA type 2 and 3 during nusinersen treatment: a prospective 3-years SMArtCARE registry study.

Mitochondrial diseases mimicking autoimmune diseases of the CNS and good response to steroids initially.

[Pseudotumor cerebri in children and adolescents at the Saarland University Medical Center: a retrospective study].

Cathepsin D as biomarker in cerebrospinal fluid of nusinersen-treated patients with spinal muscular atrophy.

Genome-wide Association Study Identifies 2 New Loci Associated With Anti-NMDAR Encephalitis.

Gene replacement therapy with onasemnogene abeparvovec in children with spinal muscular atrophy aged 24 months or younger and bodyweight up to 15 kg: an observational cohort study.

CSF Findings in Acute NMDAR and LGI1 Antibody-Associated Autoimmune Encephalitis.

Rituximab Treatment and Long-term Outcome of Patients With Autoimmune Encephalitis: Real-world Evidence From the GENERATE Registry.

Partnerships & funding